Author: Kamal, Adeela; Boehm, Marcus F; Burrows, Francis J
Title: Therapeutic and diagnostic implications of Hsp90 activation Cord-id: 0dqu3p3y Document date: 2004_6_1
ID: 0dqu3p3y
Snippet: The molecular chaperone heat-shock protein 90 (Hsp90) is involved in the stabilization and conformational maturation of many signaling proteins that are deregulated in cancers. Hsp90 inhibition results in the proteasomal degradation of these client proteins and leads to potent antitumor activity. The Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is presently in clinical trials. Recent work has identified the role of Hsp90 in multiple signal transduction pathways and revealed that the molecu
Document: The molecular chaperone heat-shock protein 90 (Hsp90) is involved in the stabilization and conformational maturation of many signaling proteins that are deregulated in cancers. Hsp90 inhibition results in the proteasomal degradation of these client proteins and leads to potent antitumor activity. The Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is presently in clinical trials. Recent work has identified the role of Hsp90 in multiple signal transduction pathways and revealed that the molecular mechanism of tumor selectivity by Hsp90 inhibitors is the result of an activated, high-affinity conformation of Hsp90 in tumors. This review discusses these recent advances in the understanding of tumor Hsp90 for the treatment and diagnosis of cancer. In addition, the role of Hsp90 in non-oncological diseases will also be discussed.
Search related documents:
Co phrase search for related documents- active agent and low affinity binding: 1
- active form and low affinity: 1, 2
- active form and lymphocyte function: 1, 2
- low affinity and lymphoma leukemia: 1
Co phrase search for related documents, hyperlinks ordered by date